MeSH Review:
Vinca
- Pathologic complete response in advanced non-small-cell lung cancer following preoperative chemotherapy: implications for the design of future non-small-cell lung cancer combined modality trials. Pisters, K.M., Kris, M.G., Gralla, R.J., Zaman, M.B., Heelan, R.T., Martini, N. J. Clin. Oncol. (1993)
- The human immune response to KS1/4-desacetylvinblastine (LY256787) and KS1/4-desacetylvinblastine hydrazide (LY203728) in single and multiple dose clinical studies. Petersen, B.H., DeHerdt, S.V., Schneck, D.W., Bumol, T.F. Cancer Res. (1991)
- Increase of cyclic adenosine 3':5'-monophosphate concentration in transplantable lymphoma cells by vinca alkaloids. Kotani, M., Koizumi, Y., Yamada, T., Kawasaki, A., Akabane, T. Cancer Res. (1978)
- Serum protein reduction of the enhancement of methotrexate accumulation by vincristine and 4'-demethylepipodophyllotoxin in the Ehrlich ascites tumor cell in vitro. Gewirtz, D.A. Cancer Res. (1985)
- Functional studies of P-glycoprotein in inside-out plasma membrane vesicles derived from murine erythroleukemia cells overexpressing MDR 3. Properties and kinetics of the interaction of vinblastine with P-glycoprotein and evidence for its active mediated transport. Schlemmer, S.R., Sirotnak, F.M. J. Biol. Chem. (1994)
- Analysis of the MRP4 drug resistance profile in transfected NIH3T3 cells. Lee, K., Klein-Szanto, A.J., Kruh, G.D. J. Natl. Cancer Inst. (2000)
- Expression of a human complementary DNA for the multidrug resistance gene in murine hematopoietic precursor cells with the use of retroviral gene transfer. McLachlin, J.R., Eglitis, M.A., Ueda, K., Kantoff, P.W., Pastan, I.H., Anderson, W.F., Gottesman, M.M. J. Natl. Cancer Inst. (1990)
- Taxol: a novel investigational antimicrotubule agent. Rowinsky, E.K., Cazenave, L.A., Donehower, R.C. J. Natl. Cancer Inst. (1990)
- A novel jasmonate- and elicitor-responsive element in the periwinkle secondary metabolite biosynthetic gene Str interacts with a jasmonate- and elicitor-inducible AP2-domain transcription factor, ORCA2. Menke, F.L., Champion, A., Kijne, J.W., Memelink, J. EMBO J. (1999)
- Genetic transfer of non-P-glycoprotein-mediated multidrug resistance (MDR) in somatic cell fusion: dissection of a compound MDR phenotype. Eijdems, E.W., Borst, P., Jongsma, A.P., de Jong, S., de Vries, E.G., van Groenigen, M., Versantvoort, C.H., Nieuwint, A.W., Baas, F. Proc. Natl. Acad. Sci. U.S.A. (1992)
- Prostaglandin F2 alpha in the treatment of vinca alkaloid-induced ileus. Saito, H., Yamamoto, T., Kimura, M., Shimokata, K. Am. J. Med. (1993)
- A reduction in energy-dependent amino acid transport by microtubular inhibitors in Ehrlich ascites tumor cells. Fyfe, M.J., Loftfield, S., Goldman, I.D. J. Cell. Physiol. (1975)
- Potentiation of radiation therapy by vinorelbine (Navelbine) in non-small cell lung cancer. Edelstein, M.P., Wolfe, L.A., Duch, D.S. Semin. Oncol. (1996)
- Vinorelbine and carboplatin in recurrent and/or metastatic squamous cell carcinoma of the head and neck. Kornek, V., Scheithauer, W., Glaser, C., Toth, J., Duman, M., Formanek, M., Hejna, M., Kornfehl, J. Oncology (1999)
- Chemoimmunoconjugate development for ovarian carcinoma therapy: preclinical studies with vinca alkaloid-monoclonal antibody constructs. Apelgren, L.D., Bailey, D.L., Briggs, S.L., Barton, R.L., Guttman-Carlisle, D., Koppel, G.A., Nichols, C.L., Scott, W.L., Lindstrom, T.D., Baker, A.L. Bioconjug. Chem. (1993)
- Additivity of dilantin and vinblastine inhibitory effects on microtubule assembly. Lobert, S., Ingram, J.W., Correia, J.J. Cancer Res. (1999)
- Abnormally banded chromosomal regions in doxorubicin-resistant B16-BL6 murine melanoma cells. Slovak, M.L., Hoeltge, G.A., Ganapathi, R. Cancer Res. (1986)
- Reversal of Vinca alkaloid resistance but not multiple drug resistance in human leukemic cells by verapamil. Beck, W.T., Cirtain, M.C., Look, A.T., Ashmun, R.A. Cancer Res. (1986)
- Comparative effects of vindesine, vinblastine, and vincristine on mitotic arrest and hormonal response of L1210 leukemia cells. Howard, S.M., Theologides, A., Sheppard, J.R. Cancer Res. (1980)
- Plasma pharmacokinetics of vinblastine and the investigational Vinca alkaloid N-(deacetyl-O-4-vinblastoyl-23)-L-ethyl isoleucinate in mice as determined by high-performance liquid chromatography. van Tellingen, O., Beijnen, J.H., Nooijen, W.J., Bult, A. Cancer Res. (1993)
- Atypical multiple drug resistance in a human leukemic cell line selected for resistance to teniposide (VM-26). Danks, M.K., Yalowich, J.C., Beck, W.T. Cancer Res. (1987)
- Snail neurons as a possible model for testing neurotoxic side effects of antitumor agents: paracrystal formation by Vinca alkaloids. Müller, L.J., Moorer-van Delft, C.M., Roubos, E.W. Cancer Res. (1988)
- Mutation of a single conserved tryptophan in multidrug resistance protein 1 (MRP1/ABCC1) results in loss of drug resistance and selective loss of organic anion transport. Ito, K., Olsen, S.L., Qiu, W., Deeley, R.G., Cole, S.P. J. Biol. Chem. (2001)
- Inhibition of phytohemagglutinin-, periodate- and A23187-induced lymphocyte transformation by vinca alkaloids. Schultz, J.C., Martin, J.M., Shahidi, N.T. Exp. Cell Res. (1979)
- Role of chemotherapy in the treatment of lung cancer: evolving strategies for non-small cell histologies. Muggia, F.M., Blum, R.H., Foreman, J.D. Int. J. Radiat. Oncol. Biol. Phys. (1984)
- Frequency and prognostic importance of pretreatment clinical characteristics in patients with advanced non-small-cell lung cancer treated with combination chemotherapy. O'Connell, J.P., Kris, M.G., Gralla, R.J., Groshen, S., Trust, A., Fiore, J.J., Kelsen, D.P., Heelan, R.T., Golbey, R.B. J. Clin. Oncol. (1986)
- Biological characterization of multidrug-resistant human colon carcinoma sublines induced/selected by two methods. Yang, L.Y., Trujillo, J.M. Cancer Res. (1990)
- Atypical multidrug resistance in a therapy-induced drug-resistant human leukemia cell line (LALW-2): resistance to Vinca alkaloids independent of P-glycoprotein. Haber, M., Norris, M.D., Kavallaris, M., Bell, D.R., Davey, R.A., White, L., Stewart, B.W. Cancer Res. (1989)
- Treatment of idiopathic thrombocytopenic purpura (ITP). Ahn, Y.S., Harrington, W.J. Annu. Rev. Med. (1977)
- Verapamil-mediated sensitization of doxorubicin-selected pleiotropic resistance in human sarcoma cells: selectivity for drugs which produce DNA scission. Harker, W.G., Bauer, D., Etiz, B.B., Newman, R.A., Sikic, B.I. Cancer Res. (1986)
- Extensive contribution of the multidrug transporters P-glycoprotein and Mrp1 to basal drug resistance. Allen, J.D., Brinkhuis, R.F., van Deemter, L., Wijnholds, J., Schinkel, A.H. Cancer Res. (2000)
- Detoxication of vinca alkaloids by human P450 CYP3A4-mediated metabolism: implications for the development of drug resistance. Yao, D., Ding, S., Burchell, B., Wolf, C.R., Friedberg, T. J. Pharmacol. Exp. Ther. (2000)
- Lipids: A key role in multidrug resistance? (Review). Pallarés-Trujillo, J., López-Soriano, F.J., Argilés, J.M. Int. J. Oncol. (2000)
- Identification and characterization of the canine multidrug resistance-associated protein. Ma, L., Pratt, S.E., Cao, J., Dantzig, A.H., Moore, R.E., Slapak, C.A. Mol. Cancer Ther. (2002)
- An update on the anticancer effects of a combination of chemotherapy and hyperthermia. Bull, J.M. Cancer Res. (1984)
- Antitumor xenograft activity with a conjugate of a Vinca derivative and the squamous carcinoma-reactive monoclonal antibody PF1/D. Johnson, D.A., Laguzza, B.C. Cancer Res. (1987)
- In vitro antagonism between cisplatin and vinca alkaloids. Lee, K., Tanaka, M., Kanamaru, H., Hashimura, T., Yamamoto, I., Konishi, J., Kuze, F. Br. J. Cancer (1989)
- Molecular characterization of a cytokinin-inducible periwinkle protein showing sequence homology with pathogenesis-related proteins and the Bet v 1 allergen family. Carpin, S., Laffer, S., Schoentgen, F., Valenta, R., Chénieux, J.C., Rideau, M., Hamdi, S. Plant Mol. Biol. (1998)
- Progesterone biotransformation by plant cell suspension cultures. Yagen, B., Gallili, G.E., Mateles, R.I. Appl. Environ. Microbiol. (1978)